USFDA completes routine cGMP inspection at formulations manufacturing facility of Dr. Reddy's

30 Oct 2023 Evaluate

United States Food & Drug Administration (USFDA) has completed a routine cGMP inspection at Dr. Reddy's Laboratories’ formulations manufacturing facility (FTO-3) in Bachupally, Hyderabad. The inspection was conducted from October 19, 2023 to October 27, 2023. USFDA has issued a Form 483 with ten observations. 

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1235.30 0.15 (0.01%)
27-Jan-2026 14:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1624.95
Dr. Reddys Lab 1235.30
Cipla 1314.60
Zydus Lifesciences 887.35
Lupin 2125.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×